BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 20884019)

  • 1. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation.
    Kukucka M; Potapov E; Stepanenko A; Weller K; Mladenow A; Kuppe H; Habazettl H
    J Thorac Cardiovasc Surg; 2011 Apr; 141(4):1009-14. PubMed ID: 20884019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial.
    Potapov E; Meyer D; Swaminathan M; Ramsay M; El Banayosy A; Diehl C; Veynovich B; Gregoric ID; Kukucka M; Gromann TW; Marczin N; Chittuluru K; Baldassarre JS; Zucker MJ; Hetzer R
    J Heart Lung Transplant; 2011 Aug; 30(8):870-8. PubMed ID: 21530317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.
    Critoph C; Green G; Hayes H; Baumwol J; Lam K; Larbalestier R; Chih S
    Artif Organs; 2016 Jan; 40(1):106-14. PubMed ID: 25994765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative Hemodynamic and Echocardiographic Measurements Associated With Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Gudejko MD; Gebhardt BR; Zahedi F; Jain A; Breeze JL; Lawrence MR; Shernan SK; Kapur NK; Kiernan MS; Couper G; Cobey FC
    Anesth Analg; 2019 Jan; 128(1):25-32. PubMed ID: 29878942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation.
    Wagner F; Dandel M; Günther G; Loebe M; Schulze-Neick I; Laucke U; Kuhly R; Weng Y; Hetzer R
    Circulation; 1997 Nov; 96(9 Suppl):II-291-6. PubMed ID: 9386113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide inhalation modulates endothelin-1 plasma concentration gradients following left ventricular assist device implantation.
    Wagner F; Buz S; Neumeyer HH; Hetzer R; Hocher B
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S89-91. PubMed ID: 15838368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
    Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
    JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
    Antoniou T; Prokakis C; Athanasopoulos G; Thanopoulos A; Rellia P; Zarkalis D; Kogerakis N; Koletsis EN; Bairaktaris A
    Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Right Ventricle Failure After Continuous Flow Left Ventricular Assist Device: A Biventricular Finite-Element and Lumped-Parameter Analysis.
    Scardulla F; Agnese V; Romano G; Di Gesaro G; Sciacca S; Bellavia D; Clemenza F; Pilato M; Pasta S
    Cardiovasc Eng Technol; 2018 Sep; 9(3):427-437. PubMed ID: 29700783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled Nitric Oxide Augments Left Ventricular Assist Device Capacity by Ameliorating Secondary Right Ventricular Failure.
    Lovich MA; Pezone MJ; Wakim MG; Denton RJ; Maslov MY; Murray MR; Tsukada H; Agnihotri AK; Roscigno RF; Gamero LG; Gilbert RJ
    ASAIO J; 2015; 61(4):379-85. PubMed ID: 25710771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary artery pulsatility index predicts prolonged inotrope/pulmonary vasodilator use after implantation of continuous flow left ventricular assist device.
    Aggarwal V; Tume SC; Rodriguez M; Adachi I; Cabrera AG; Tunuguntla H; Qureshi AM
    Congenit Heart Dis; 2019 Nov; 14(6):1130-1137. PubMed ID: 31802608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute right heart failure after hemorrhagic shock and trauma pneumonectomy-a management approach: A blinded randomized controlled animal trial using inhaled nitric oxide.
    Lubitz AL; Sjoholm LO; Goldberg A; Pathak A; Santora T; Sharp TE; Wallner M; Berretta RM; Poole LA; Wu J; Wolfson MR
    J Trauma Acute Care Surg; 2017 Feb; 82(2):243-251. PubMed ID: 28107308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables.
    Aissaoui N; Salem JE; Paluszkiewicz L; Morshuis M; Guerot E; Gorria GM; Fagon JY; Gummert J; Diebold B
    Arch Cardiovasc Dis; 2015 May; 108(5):300-9. PubMed ID: 25863429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
    Demirozu ZT; Arat N; Kucukaksu DS
    Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy.
    Vikholm P; Schiller P; Johansson J; Hellgren L
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):625-31. PubMed ID: 23477692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled nitric oxide preserves ventricular function during resuscitation using a percutaneous mechanical circulatory support device in a porcine cardiac arrest model: an echocardiographic myocardial work analysis.
    Nix C; Zayat R; Ebeling A; Goetzenich A; Chandrasekaran U; Rossaint R; Hatam N; Derwall M
    BMC Cardiovasc Disord; 2021 Apr; 21(1):189. PubMed ID: 33865330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.